Home > Insider Trading > Filing (0001209191-10-054123)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890846	Uroplasty Inc	UPI	Surgical & Medical Instruments & Apparatus (3841)	411719250

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1374605	P James Stauner	272 East Deerpath Rd Suite 350 Lake Forest IL 60045		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-08	45,000	$1.82	55,725	No	4	M	Direct
Common Stock	Disposition	2010-11-08	28,600	$5.59	27,125	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	non-qualified stock options	Disposition	2010-11-08	45,000	$1.82	45,000	$1.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2006-08-28	2011-08-27	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	non-qualified stock options	$0.77	2009-09-15	2014-09-14	15,000	15,000	Direct
Common Stock	non-qualified stock options	$4.16	2011-09-14	2017-09-13	6,175	6,175	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-09-14	15,000	15,000	Direct
2017-09-13	6,175	6,175	Direct

Footnotes

Restricted stock subject to risk of forfeiture that lapses six months from the grant date (September 14, 2010).
Fully vested.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions pursuant to a 10b5-1 plan adopted by Mr. Stauner in September 2010 at prices ranging from $5.50 to $5.74 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).